Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,040 total articles
Vor Biopharma (VOR) has moved decisively from an earlier oncology posture into autoimmune disease with telitacicept. Positive Phase 3 signals in China, a string of financings that together exceed $250M, and an enterprise value that still leaves upside if Western registrational data confirm efficacy make VOR a tactical long for risk-tolerant traders…
STAG Industrial ($STAG) looks buyable on a mid-term (45 trading days) basis. The company’s dividend increase, large portfolio scale and technical momentum support a re-rating. Valuation is reasonable at roughly $7.5B market cap with a P/E near 30 and a ~3.9% yield. Enter $39.15, target $44.00, stop $36.00.
Marathon Petroleum (MPC) is a scaled-refiner and midstream operator trading at a reasonable multiple with strong free cash flow. Geopolitical attention has centered on Iran, but the longer-lasting distortions from Russian export re-routing are a more durable tailwind for U.S. refiners. This trade idea outlines why to own MPC over the next 45 tradin…
South32 looks primed for a corporate reset if management executes targeted asset sales. The market underprices potential cash returns and a simpler portfolio. This trade captures a mid-term rerating while limiting downside with a tight stop.
Microsoft shares have slipped from last year’s highs amid Copilot execution concerns, a class-action suit, and 4,800 job cuts. Fundamentals remain robust - $2.91T market cap, $72.9B free cash flow, 30% ROE, and a diversified profit mix anchored by Intelligent Cloud. I upgrade to Buy and propose a long trade with a $392 entry, $360 stop and $450 tar…
Exponent (EXPO) is a niche engineering and scientific consultancy that benefits when products, regulations, and technologies get more complicated. With FY2025 revenue of $582.0M, free cash flow of $113.4M, and guidance calling for high-single-digit growth in FY2026, the stock looks actionable on a mid-term swing. I recommend a controlled long with …
Zoom trades at roughly 12x earnings with ~7.7% free-cash-flow yield and a meaningful equity stake in Anthropic. The fundamentals and cash generation support a long-term buy, but European digital-sovereignty pressure, intensifying AI competition, and execution risk mean position sizing and a disciplined stop are essential.
Netflix heads into Q2 with live programming as the clearest incremental growth lever. Fundamentals remain healthy - $322B market cap, 24x earnings, strong cash flow and ROE - yet investor sentiment is compressed after a steep multi-quarter sell-off. I rate shares a Hold for core positions and outline a tactical swing trade for traders seeking asymm…
DHT Holdings trades at a bargain-like multiple with a near-9% yield, recent asset sales that added ~$95M of net cash and early delivery of newbuildings that should lift earning power. The market has already baked in much of the geopolitical and charter-rate risk; we see a mid-term long trade with defined entry, stop and target that offers attractiv…
Limbach (LMB) has shifted its revenue mix toward Owner Direct Relationships, which now drive the majority of sales and produce recurring, higher-margin work. A recent pullback to $76.75 offers a reasonable entry for a mid-term swing trade. Fundamentals - modest leverage, positive ROE, and meaningful free cash flow - support the bull case, while val…
CoreWeave (CRWV) faces accelerating competitive pressure from fast-growing Nebius and a potential deflationary shock from Meta's compute-as-a-service move. Fundamentals show revenue growth but mounting losses, a leveraged balance sheet and weakening technicals. This trade idea lays out an actionable short: entry $83.00, stop $92.00, target $68.00, …
Meta is using its scale to vertically integrate AI compute, which undermines standalone neocloud and hardware-adjacent plays while improving Meta’s margin optionality. The trade: buy Meta on any sustained weakness around current levels with a mid-term (45 trading days) target of $700, tight stop at $575.
Palantir's enterprise AI platform is moving from bespoke deployments to repeatable product offerings. Strong growth, high margins, improving technicals, and a recent pullback make a disciplined long trade attractive over the next 45 trading days, provided Palantir sustains commercial expansion and earnings power.
Nvidia's leadership in AI compute makes it the natural partner for software platforms like Palantir. If a commercial partnership or strategic deal surfaces, NVDA should see meaningful re-rating. This trade idea lays out a mid-term swing entry at $197.81, a stop at $185.00 and a primary target at $236.54 (52-week high), with clear catalysts and a ri…
ICICI Bank (IBN) looks positioned to benefit from a favorable policy backdrop and improving loan demand. Technical momentum and reasonable valuation metrics support a tactical long over the next 45 trading days. Entry $29.50, target $34.50, stop $28.00.
Nvidia remains the dominant supplier of AI compute and networking hardware with industry-leading margins, massive free cash flow and a fortress balance sheet. At $195, the stock offers a tactical long opportunity for disciplined traders: entry $195.00, stop $170.00, target $260.00 over a long-term 180 trading day horizon. The upside is driven by co…
Achieve Life Sciences (ACHV) carries headline risk from a recent Complete Response Letter, but fundamentals and setup support a constructive position trade. The company still commands a market cap near $660M, has a meaningful NDA timeline and $45M capital raise behind the program. We outline an explicit entry, stop and $12 target on a 180-trading-d…
Gorman-Rupp sells pumps — but recent demand from data-center cooling and infrastructure has turned this sleepy small-cap into a volatile, opportunity-rich name. Valuation looks full at ~38x earnings, yet cash flow, a healthy balance sheet and a tight float mean a disciplined, mid-term long can pay off. Below: why I’m watching GRC, the concrete trad…
Bioventus (BVS) has stronger cash generation, a cleaner credit profile and an end-market tailwind behind osteoarthritis and fracture-healing therapies. At roughly $11.69 today and a market cap near $1.0B, the stock looks fairly valued vs. fundamentals but offers an asymmetric swing trade: buy now for a re-rating toward a mid-30s P/E as execution an…
CoreWeave has pulled back sharply despite accelerating AI infrastructure demand and a scalable, capex-efficient model. We upgrade to Buy and lay out a core trade with clear entry, stop and targets across horizons. The setup favors disciplined size and patience given short-term volatility.
GoDaddy (GDDY) is trading well below its prior highs, but the market has likely overreacted to headline risk and is underestimating the company's ability to monetize AI in its Applications & Commerce segment. With free cash flow of $1.64B, a price-to-free-cash-flow near 7, and a PE roughly 13-14x, the setup supports a long trade with defined risk a…
Nu Holdings is one of the fastest-growing digital banks in Latin America with 135 million customers and Q1 2026 revenue of $5.32 billion. The growth runway is large, but currency, credit and execution risks are real. This trade idea lays out a disciplined long entry with a $13.80 pivot, a $11.50 stop and a $19.00 target over a 180-trading-day horiz…
Technip Energies (THNPY) is an engineering-and-technology play on energy transition projects (LNG, SAF, hydrogen and refinery modernization). The stock looks reasonable on valuation - market cap ~$7.19B, P/E ~17 and a 2.1% yield - but technicals and recent strength argue for patience. I prefer to buy a pullback to $37.50 with a $34.50 stop and $48.…
Urban Outfitters is posting stronger comps than many apparel peers, delivering record quarterly revenue and expanding subscription growth. The stock trades at a reasonable multiple versus growth and offers an asymmetric risk/reward for a mid-term swing trade. Technicals are mixed, so position sizing and a tight stop matter.
Altimmune ($ALT) is worth revisiting on a trade basis. Recent 48-week MASH data and a refreshed balance sheet remove near-term financing as the main drag. A potential AUD (alcohol use disorder) readout expected in Q3 2026 is a binary catalyst that could re-rate the stock toward prior highs if positive. We upgrade to a tactical long with defined ent…
